Pensacola news you missed: Grover's opens in Milton, Blue Angels face lawsuit
With a subscription to the Pensacola News Journal, you will receive full access to the work done by our journalists and photographers as they head out every day to help inform and explain the important issues affecting your community.
Pensacola makes $1.2 million deal to buy old Escambia Clinic on Palafox
The city of Pensacola has negotiated a contract to buy a longstanding eyesore on N. Palafox, Escambia County's old Medical Center Clinic, and the mayor says they're using grant money from the Hollis T. Williams project to cover the cost.
According to the contract, the purchase price is $1,275,000 for the four-story building at 1750 N. Palafox and two adjacent parcels of land that are all owned by Real Business Consultants, Inc.
Real Business Consultants bought the building from ECUA in 2016 for $75,000. About a year ago, the company listed it for close to $2 million.
Full story: Pensacola makes $1.2 million deal to buy old Escambia Clinic on Palafox
FINALLY! Grover's Milton restaurant opened Thursday. Here's a look inside
The wait is over for Milton's new Grover's, opened to the public on July 24 at 5614 Stewart St., following over a year of eager community anticipation.
The sparkling new Milton restaurant carries over the old-school diner feel of the original location, Grover's Fingers & Wings at 9418 N. Davis Highway, but now with a drive-thru, glittery cherry red booths, black-and-white checkered floors and quadruple the seating.
Keep reading: FINALLY! Grover's Milton restaurant opening Thursday. Here's a sneak peek inside
Pensacola accused of 'embarrassing' rollout of garbage pickup as recycling returns; considering credits for customers
Many Pensacola residents are upset over the city's switch to weekly garbage pickup and what they say is a lack of communication about the change.
Residents have taken to social media to voice anger about the changes, with some upset over the change and others upset over missed pickups on their single pick-up day.
Anger online was reflected in comments at the Pensacola City Council meeting on July 17, where Councilman Charles Bare called the rollout of the new changes 'embarrassing.'
'I want to apologize to the residents of District 2 for what's happening with sanitation,' Bare said. 'It's been embarrassing to be a council member.'
Full story: Pensacola accused of 'embarrassing' rollout of garbage pickup as recycling returns
Pensacola is now considering an option to credit sanitation customers after the botched transition to once-a-week residential garbage pickup frustrated residents.
Pensacola Mayor D.C. Reeves said the communications surrounding the transition were 'not up to our standard.'
Full story: Pensacola looking into bill credits after botching change to once weekly garbage pickup
Women on Pensacola streets are trafficked every day. It's difficult to prove and stop.
Lisha Banks has been living off and on the streets for years, camping in the woods, along rail lines, or wherever the 59-year-old can find a quiet place to be. There's no such thing as a 'safe' place to live for most women on the street.
They are disproportionately vulnerable to violence, including sexual violence from people they know and others they don't.
In fact, escaping violence can be the reason why some women, like Lisha, end up homeless.
'It's hard. If you're not tough bad things happen. They get raped all the time,' Banks said. 'When I was at Beggs Lane, I had a 28-year-old try to rape me. Thank God a friend came by and got his attention and I could get out of there. You have to keep one eye open and whatever weapons you can have, and still that's not going to do any good if you got 10 guys coming on you, especially the older women.'
Keep reading: Women on Pensacola streets are trafficked every day. It's difficult to prove and stop.
Blue Angels sued for killing Seattle woman's cat. What Pensacola has to say about that
A Seattle, Washington, woman has filed a lawsuit against the U.S. Navy's elite high-flying aerobatics squadron, the Blue Angels, blaming them for killing 'the greatest cat that ever lived' with the 'sonic assaults' they inflict during their annual August show over Puget Sound.
Lauren Ann Lombardi filed the lawsuit in federal court alleging that her 14-year-old cat 'Layla,' which she loved like a daughter, died as a result of the Blue Angels 'auditory carpet bombing.'
The suit says the elderly cat's health started deteriorating after the Blue Angels' show in August 2024 and their most recent show was the final straw.
Blue Angels lawsuit: Blue Angels sued for killing Seattle woman's cat. What Pensacola has to say about that
This article originally appeared on Pensacola News Journal: Top Pensacola news: Grover's opens, Blue Angels face lawsuit
Solve the daily Crossword
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
24 minutes ago
- Yahoo
Trump again slams Fed chair Powell after rates hold
WASHINGTON (Reuters) -U.S. President Donald Trump again criticised Federal Reserve Chairman Jerome Powell on Thursday, a day after the U.S. central bank held interest rates steady in a 9-2 vote. "Jerome 'Too Late' Powell has done it again!!! He is TOO LATE," Trump wrote in a post on his social media platform. "Put another way,'Too Late' is a TOTAL LOSER, and our Country is paying the price!"
Yahoo
24 minutes ago
- Yahoo
AMG Reports Financial and Operating Results for the Second Quarter and First Half of 2025
Company reports Diluted EPS of $2.80, Economic EPS of $5.39 in the second quarter of 2025 Positive net client cash flows of more than $8 billion, driven by ongoing momentum in private markets and liquid alternatives New partnership with Montefiore Investment further diversifies AMG's business and expands its participation in private markets Economic Earnings per share of $5.39 for the quarter, an increase of 15% relative to prior-year quarter Repurchased ~$100 million in common stock, bringing total share repurchases to ~$273 million in the first half of the year WEST PALM BEACH, Fla., July 31, 2025 (GLOBE NEWSWIRE) -- AMG, a strategic partner to leading independent investment management firms globally, today reported its financial and operating results for the second quarter and six months ended June 30, 2025. Jay C. Horgen, Chief Executive Officer of AMG, said:'In the second quarter, AMG reported growth of 15% in Economic Earnings per share relative to the year-ago quarter, reflecting the disciplined execution of our capital allocation strategy and the increasing momentum in our business. Net client cash flows of more than $8 billion firmwide were driven by record flows into alternatives, reflecting ongoing strength in private markets fundraising and growing client demand for liquid alternative strategies. 'Through strong ongoing execution of our strategy, we are accelerating the evolution of AMG's business toward areas of secular growth. AMG's Affiliates managing private markets and liquid alternative strategies generated net client inflows of approximately $33 billion in the first half of the year, reflecting the ongoing demand for our Affiliates' specialized strategies. In addition, we recently announced a new partnership with Montefiore, a leading European private equity firm focused on the services sector. So far in 2025, we have announced four new partnerships with firms collectively managing approximately $24 billion in alternative strategies, underscoring the ongoing demand for AMG's unique approach, which magnifies the competitive advantages of partner-owned firms while also preserving their independence. 'With our excellent capital position and distinct competitive advantages, including our worldwide reputation as a collaborative strategic partner to the highest-quality independent firms, we are uniquely positioned to execute on our opportunity set. We remain confident in our ability to generate meaningful additional shareholder value over time, as we invest in new and existing Affiliates while also returning excess capital to shareholders within our disciplined capital allocation framework.' FINANCIAL HIGHLIGHTS Three Months Ended Six Months Ended (in millions, except as noted and per share data) 6/30/2024 6/30/2025 6/30/2024 6/30/2025 Operating Performance Measures AUM (at period end, in billions) $ 701.0 $ 771.0 $ 701.0 $ 771.0 Average AUM (in billions) 693.1 736.6 686.5 724.3 Net client cash flows (in billions) 0.9 8.1 (2.9 ) 7.7 Aggregate fees 1,098.1 1,173.5 2,569.7 2,443.9 Financial Performance Measures Net income (controlling interest) $ 76.0 $ 84.3 $ 225.8 $ 156.6 Earnings per share (diluted)(1) 2.26 2.80 6.49 5.01 Supplemental Performance Measures(2) Adjusted EBITDA (controlling interest) $ 217.5 $ 219.7 $ 477.3 $ 447.9 Economic net income (controlling interest) 155.9 159.2 342.6 317.9 Economic earnings per share 4.67 5.39 10.06 10.58 For additional information on our Supplemental Performance Measures, including reconciliations to GAAP, see the Financial Tables and Notes. Capital Management During the second quarter of 2025, the Company repurchased approximately $100 million in common stock, bringing total share repurchases to approximately $273 million in the first half of the year, and announced a second-quarter cash dividend of $0.01 per share of common stock, payable August 25, 2025 to stockholders of record as of the close of business on August 11, 2025. About AMGAMG (NYSE: AMG) is a strategic partner to leading independent investment management firms globally. AMG's strategy is to generate long‐term value by investing in high-quality independent partner-owned firms, through a proven partnership approach, and allocating resources across AMG's unique opportunity set to the areas of highest growth and return. Through its distinctive approach, AMG magnifies its Affiliates' existing advantages and actively supports their independence and ownership culture. As of June 30, 2025, AMG's aggregate assets under management were approximately $771 billion across a diverse range of private markets, liquid alternative, and differentiated long-only investment strategies. For more information, please visit the Company's website at Conference Call, Replay, and Presentation InformationA conference call will be held with AMG's management at 11:00 a.m. Eastern time today. Parties interested in listening to the conference call should dial 1-877-407-8291 (U.S. calls) or 1-201-689-8345 (non-U.S. calls) shortly before the call begins. The conference call will also be available for replay beginning approximately one hour after the conclusion of the call. To hear a replay of the call, please dial 1-877-660-6853 (U.S. calls) or 1-201-612-7415 (non-U.S. calls) and provide conference ID 13754341. The live call and replay of the session and a presentation highlighting the Company's performance can also be accessed via AMG's website at Investor and Media Relations: Patricia Figueroa+1 (617) 747-3300ir@ Financial Tables FollowASSETS UNDER MANAGEMENT - STATEMENTS OF CHANGES Alternatives Differentiated Long-Only BY STRATEGY - QUARTER TO DATE Private Markets Liquid Alternatives Equities Multi-Asset & Fixed Income Total AUM, March 31, 2025 $ 140.3 $ 154.8 $ 302.1 $ 115.0 $ 712.2 Client cash inflows and commitments 7.8 16.8 10.7 5.0 40.3 Client cash outflows (0.0 ) (5.3 ) (21.2 ) (5.7 ) (32.2 ) Net client cash flows 7.8 11.5 (10.5 ) (0.7 ) 8.1 New investments — 12.4 — — 12.4 Market changes 1.3 1.3 24.0 3.8 30.4 Foreign exchange 0.7 2.9 5.4 1.1 10.1 Realizations and distributions (net) (0.7 ) (0.1 ) (0.0 ) (0.1 ) (0.9 ) Other — (1.1 ) (0.0 ) (0.2 ) (1.3 ) AUM, June 30, 2025 $ 149.4 $ 181.7 $ 321.0 $ 118.9 $ 771.0 Alternatives Differentiated Long-Only BY STRATEGY - YEAR TO DATE Private Markets Liquid Alternatives Equities Multi-Asset &Fixed Income Total AUM, December 31, 2024 $ 135.4 $ 140.7 $ 316.2 $ 115.6 $ 707.9 Client cash inflows and commitments 11.3 32.7 19.5 9.8 73.3 Client cash outflows (0.1 ) (11.0 ) (43.7 ) (10.8 ) (65.6 ) Net client cash flows 11.2 21.7 (24.2 ) (1.0 ) 7.7 New investments 1.7 12.4 — — 14.1 Market changes 1.8 3.6 22.0 3.5 30.9 Foreign exchange 0.9 4.4 7.1 1.4 13.8 Realizations and distributions (net) (1.6 ) (0.0 ) (0.1 ) (0.3 ) (2.0 ) Other — (1.1 ) 0.0 (0.3 ) (1.4 ) AUM, June 30, 2025 $ 149.4 $ 181.7 $ 321.0 $ 118.9 $ 771.0 CONSOLIDATED STATEMENTS OF INCOME Three Months Ended (in millions, except per share data) 6/30/2024 6/30/2025 Consolidated revenue $ 500.3 $ 493.2 Consolidated expenses: Compensation and related expenses 215.3 263.7 Selling, general and administrative 89.4 95.7 Intangible amortization and impairments 7.3 6.3 Interest expense 33.5 34.5 Depreciation and other amortization 3.1 2.5 Other expenses (net) 10.8 10.0 Total consolidated expenses 359.4 412.7 Equity method income (net)(3) 18.1 65.6 Investment and other income 19.3 25.5 Income before income taxes 178.3 171.6 Income tax expense 43.3 35.7 Net income 135.0 135.9 Net income (non-controlling interests) (59.0 ) (51.6 ) Net income (controlling interest) $ 76.0 $ 84.3 Average shares outstanding (basic) 31.5 28.5 Average shares outstanding (diluted) 35.3 31.4 Earnings per share (basic) $ 2.42 $ 2.96 Earnings per share (diluted)(1) $ 2.26 $ 2.80 RECONCILIATIONS OF SUPPLEMENTAL PERFORMANCE MEASURES(2) Three Months Ended (in millions, except per share data) 6/30/2024 6/30/2025 Net income (controlling interest) $ 76.0 $ 84.3 Intangible amortization and impairments 65.6 31.0 Intangible-related deferred taxes 14.7 14.6 Other economic items(4) (0.4 ) 29.3 Economic net income (controlling interest) $ 155.9 $ 159.2 Average shares outstanding (adjusted diluted) 33.4 29.5 Economic earnings per share $ 4.67 $ 5.39 Net income (controlling interest) $ 76.0 $ 84.3 Interest expense 33.5 34.4 Income taxes 42.3 35.1 Intangible amortization and impairments 65.6 31.0 Other items(4) 0.1 34.9 Adjusted EBITDA (controlling interest) $ 217.5 $ 219.7 See Notes for additional information. CONSOLIDATED STATEMENTS OF INCOME Six Months Ended (in millions, except per share data) 6/30/2024 6/30/2025 Consolidated revenue $ 1,000.3 $ 989.8 Consolidated expenses: Compensation and related expenses 455.7 494.1 Selling, general and administrative 181.1 190.4 Intangible amortization and impairments 14.5 89.6 Interest expense 63.4 68.6 Depreciation and other amortization 6.1 5.3 Other expenses (net) 19.9 21.6 Total consolidated expenses 740.7 869.6 Equity method income (net)(3) 135.7 140.9 Investment and other income 37.2 37.1 Income before income taxes 432.5 298.2 Income tax expense 98.7 63.1 Net income 333.8 235.1 Net income (non-controlling interests) (108.0 ) (78.5 ) Net income (controlling interest) $ 225.8 $ 156.6 Average shares outstanding (basic) 32.1 28.9 Average shares outstanding (diluted) 36.0 32.3 Earnings per share (basic) $ 7.02 $ 5.43 Earnings per share (diluted)(1) $ 6.49 $ 5.01 RECONCILIATIONS OF SUPPLEMENTAL PERFORMANCE MEASURES(2) Six Months Ended (in millions, except per share data) 6/30/2024 6/30/2025 Net income (controlling interest) $ 225.8 $ 156.6 Intangible amortization and impairments 91.2 116.8 Intangible-related deferred taxes 30.9 13.9 Other economic items(4) (5.3 ) 30.6 Economic net income (controlling interest) $ 342.6 $ 317.9 Average shares outstanding (adjusted diluted) 34.0 30.0 Economic earnings per share $ 10.06 $ 10.58 Net income (controlling interest) $ 225.8 $ 156.6 Interest expense 63.4 68.5 Income taxes 99.7 65.4 Intangible amortization and impairments 91.2 116.8 Other items(4) (2.8 ) 40.6 Adjusted EBITDA (controlling interest) $ 477.3 $ 447.9 See Notes for additional information. CONSOLIDATED BALANCE SHEETS Period Ended (in millions) 12/31/2024 6/30/2025 Assets Cash and cash equivalents $ 950.0 $ 361.0 Receivables 409.7 571.0 Investments 595.6 644.1 Goodwill 2,504.9 2,537.6 Acquired client relationships (net) 1,777.8 1,716.1 Equity method investments in Affiliates (net) 2,246.6 2,618.3 Fixed assets (net) 57.6 56.7 Other assets 288.7 302.8 Total assets $ 8,830.9 $ 8,807.6 Liabilities and Equity Payables and accrued liabilities $ 639.1 $ 692.4 Debt 2,620.2 2,621.2 Deferred income tax liability (net) 520.5 544.3 Other liabilities 402.4 474.9 Total liabilities 4,182.2 4,332.8 Redeemable non-controlling interests 350.5 336.1 Equity: Common stock 0.6 0.6 Additional paid-in capital 733.1 701.2 Accumulated other comprehensive loss (163.6 ) (125.0 ) Retained earnings 6,899.8 7,055.9 7,469.9 7,632.7 Less: treasury stock, at cost (4,124.6 ) (4,394.0 ) Total stockholders' equity 3,345.3 3,238.7 Non-controlling interests 952.9 900.0 Total equity 4,298.2 4,138.7 Total liabilities and equity $ 8,830.9 $ 8,807.6 Notes (1) Earnings per share (diluted) adjusts for the dilutive effect of the potential issuance of incremental shares of our common assume the settlement of all of our Redeemable non-controlling interests using the maximum number of shares permitted under our arrangements. The issuance of shares and the related income acquired are excluded from the calculation if an assumed purchase of Redeemable non-controlling interests would be anti-dilutive to diluted earnings per are required to apply the if-converted method to our outstanding junior convertible securities when calculating Earnings per share (diluted). Under the if-converted method, shares that are issuable upon conversion are deemed outstanding, regardless of whether the securities are contractually convertible into our common stock at that time. For this calculation, the interest expense (net of tax) attributable to these dilutive securities is added back to Net income (controlling interest), reflecting the assumption that the securities have been converted. Issuable shares for these securities and related interest expense are excluded from the calculation if an assumed conversion would be anti-dilutive to diluted earnings per following table provides a reconciliation of the numerator and denominator used in the calculation of basic and diluted earnings per share: Three Months Ended Six Months Ended (in millions) 6/30/2024 6/30/2025 6/30/2024 6/30/2025 Numerator Net income (controlling interest) $ 76.0 $ 84.3 $ 225.8 $ 156.6 Income (loss) from hypothetical settlement of Redeemable non-controlling interests, net of taxes 0.3 0.3 0.7 (1.5 ) Interest expense on junior convertible securities, net of taxes 3.4 3.4 6.7 6.7 Net income (controlling interest), as adjusted $ 79.7 $ 88.0 $ 233.2 $ 161.8 Denominator Average shares outstanding (basic) 31.5 28.5 32.1 28.9 Effect of dilutive instruments: Stock options and restricted stock units 1.9 1.0 1.9 1.1 Hypothetical issuance of shares to settle Redeemable non-controlling interests 0.2 0.2 0.3 0.6 Junior convertible securities 1.7 1.7 1.7 1.7 Average shares outstanding (diluted) 35.3 31.4 36.0 32.3 (2) As supplemental information, we provide non-GAAP performance measures of Adjusted EBITDA (controlling interest), Economic net income (controlling interest), and Economic earnings per share. We believe that many investors use our Adjusted EBITDA (controlling interest) when comparing our financial performance to other companies in the investment management industry. Management utilizes these non-GAAP performance measures to assess our performance before our share of certain non-cash GAAP expenses primarily related to the acquisition of interests in Affiliates and to improve comparability between periods. Economic net income (controlling interest) and Economic earnings per share are used by management and our Board of Directors as our principal performance benchmarks, including as one of the measures for determining executive compensation. These non-GAAP performance measures are provided in addition to, but not as a substitute for, Net income (controlling interest), Earnings per share, or other GAAP performance measures. For additional information on our non-GAAP measures, see our most recent Annual and Quarterly Reports on Form 10-K and 10-Q, respectively, which are accessible on the SEC's website at EBITDA (controlling interest) represents our performance before our share of interest expense, income and certain non-income based taxes, depreciation, amortization, impairments, gains and losses related to Affiliate Transactions, and non-cash items such as certain Affiliate equity activity, gains and losses on our contingent payment obligations, and unrealized gains and losses on seed capital, general partner commitments, and other strategic investments. Adjusted EBITDA (controlling interest) is also adjusted to include realized economic gains and losses related to these seed capital, general partner commitments, and other strategic our Economic net income (controlling interest) definition, we adjust Net income (controlling interest) for our share of pre-tax intangible amortization and impairments related to intangible assets (including the portion attributable to equity method investments in Affiliates) because these expenses do not correspond to the changes in the value of these assets, which do not diminish predictably over time. We also adjust for deferred taxes attributable to intangible assets because we believe it is unlikely these accruals will be used to settle material tax obligations. Further, we adjust for gains and losses related to Affiliate Transactions, net of tax, and other economic items. Other economic items include certain Affiliate equity activity, gains and losses related to contingent payment obligations, tax windfalls and shortfalls from share-based compensation, unrealized gains and losses on seed capital, general partner commitments, and other strategic investments, and realized economic gains and losses related to these seed capital, general partner commitments, and other strategic earnings per share represents Economic net income (controlling interest) divided by the Average shares outstanding (adjusted diluted). In this calculation, we exclude the potential shares issued upon settlement of Redeemable non-controlling interests from Average shares outstanding (adjusted diluted) because we intend to settle those obligations without issuing shares, consistent with all prior Affiliate equity purchase transactions. The potential share issuance in connection with our junior convertible securities is measured using a 'treasury stock' method. Under this method, only the net number of shares of common stock equal to the value of the junior convertible securities in excess of par, if any, are deemed to be outstanding. We believe the inclusion of net shares under a treasury stock method best reflects the benefit of the increase in available capital resources (which could be used to repurchase shares of our common stock) that occurs when these securities are converted and we are relieved of our debt following table provides a reconciliation of Average shares outstanding (adjusted diluted): Three Months Ended Six Months Ended (in millions) 6/30/2024 6/30/2025 6/30/2024 6/30/2025 Average shares outstanding (diluted) 35.3 31.4 36.0 32.3 Hypothetical issuance of shares to settle Redeemable non-controlling interests (0.2 ) (0.2 ) (0.3 ) (0.6 ) Junior convertible securities (1.7 ) (1.7 ) (1.7 ) (1.7 ) Average shares outstanding (adjusted diluted) 33.4 29.5 34.0 30.0 (3) The following table presents pre-tax equity method earnings, equity method intangible amortization and impairments, and equity method income tax, which in aggregate form Equity method income (net): Three Months Ended Six Months Ended (in millions) 6/30/2024 6/30/2025 6/30/2024 6/30/2025 Pre-tax equity method earnings $ 80.3 $ 94.1 $ 222.8 $ 193.6 Equity method intangible amortization and impairments (60.8 ) (27.0 ) (81.6 ) (45.6 ) Equity method income tax (1.4 ) (1.5 ) (5.5 ) (7.1 ) Equity method income (net) $ 18.1 $ 65.6 $ 135.7 $ 140.9 (4) For the three and six months ended June 30, 2025, other economic items and other items include a one-time expense of $30.5 million which resulted from a modification of Affiliate equity which, consistent with the definitions of our non-GAAP performance measures, has been added back to Economic net income (controlling interest) and Adjusted EBITDA (controlling interest). Forward-Looking Statements and Other Matters Certain matters discussed in this press release issued by Affiliated Managers Group, Inc. ('AMG' or the 'Company') may constitute forward-looking statements within the meaning of the federal securities laws. These statements include, but are not limited to, statements related to our expectations regarding the performance of our business, our financial results, our liquidity and capital resources, and other non-historical statements. You can identify these forward-looking statements by the use of words such as 'outlook,' 'guidance,' 'believes,' 'expects,' 'potential,' 'preliminary,' 'continues,' 'may,' 'will,' 'should,' 'seeks,' 'approximately,' 'predicts,' 'projects,' 'positioned,' 'prospects,' 'intends,' 'plans,' 'estimates,' 'pending investments,' 'anticipates,' or the negative version of these words or other comparable words. Actual results and the timing of certain events could differ materially from those projected in or contemplated by the forward-looking statements due to a number of factors, including changes in the securities or financial markets or in general economic conditions, global trade tensions and changes in trade policies, the availability of equity and debt financing, competition for acquisitions of interests in investment management firms, uncertainties relating to closing of pending investments or transactions and potential changes in the anticipated benefits thereof, the investment performance and growth rates of our Affiliates and their ability to effectively market their investment strategies, the mix of Affiliate contributions to our earnings, and other risks, uncertainties, and assumptions, including those described under the section entitled 'Risk Factors' in our most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Such factors may be updated from time to time in our periodic filings with the SEC. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this press release and in our filings with the SEC. We undertake no obligation to publicly update or review any forward-looking statements, whether as a result of new information, future developments, or otherwise, except as required by applicable law. This press release does not constitute an offer of any products, investment vehicles, or services of any AMG Affiliate. From time to time, AMG may use its website as a distribution channel of material Company information. AMG routinely posts financial and other important information regarding the Company in the Investor Relations section of its website at and encourages investors to consult that section in to access your portfolio
Yahoo
24 minutes ago
- Yahoo
Atea Pharmaceuticals to Host Second Quarter 2025 Financial Results and Business Update Conference Call on August 7, 2025
BOSTON, July 31, 2025 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced that it will host a live conference call and audio webcast on Thursday, August 7, 2025, at 4:30 p.m. ET to report financial results for the second quarter ended June 30, 2025, and to provide a business update. To access the live conference call, participants may register here. The live audio webcast of the call will be available under "Events and Presentations" in the Investor Relations section of the Atea Pharmaceuticals website at To participate via telephone, please dial 1-877-300-8521 (U.S.) or 1-412-317-6026 (International) and use conference ID number 10201618. An archive of the audio webcast will be available on Atea's website approximately two hours after the conference call and will remain available for at least 90 days following the event. About Atea Pharmaceuticals Atea is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral antiviral therapies to address the unmet medical needs of patients with serious viral infections. Leveraging Atea's deep understanding of antiviral drug development, nucleos(t)ide chemistry, biology, biochemistry and virology, Atea has built a proprietary nucleos(t)ide prodrug platform to develop novel product candidates to treat single stranded ribonucleic acid, or ssRNA, viruses, which are a prevalent cause of serious viral diseases. Atea plans to continue to build its pipeline of antiviral product candidates by augmenting its nucleos(t)ide platform with other classes of antivirals that may be used in combination with its nucleos(t)ide product candidates. Atea's lead program and current focus is on the development of the combination of bemnifosbuvir, a nucleotide analog polymerase inhibitor, and ruzasvir, an NS5A inhibitor, to treat HCV. For more information, please visit Forward-Looking Statements This press release includes 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements in this press release include but are not limited to the Company's plans relating to the date and time of the anticipated conference call and audio webcast. When used herein, words including 'may,' 'will,' 'anticipates,' 'plans,' and similar expressions are intended to identify forward-looking statements. In addition, any statements or information that refer to expectations, beliefs, plans, projections, objectives, performance or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking. All forward-looking statements are based upon the Company's current expectations and various assumptions. The Company believes there is a reasonable basis for its expectations and beliefs, but they are inherently uncertain. The Company may not realize its expectations, and its beliefs may not prove correct. Actual results could differ materially from those described or implied by such forward-looking statements as a result of various important factors, including, without limitation, the important factors discussed and updated from time to time under the caption 'Risk Factors' in the reports the Company files with the SEC, including annual reports on Form10-K, quarterly reports on Form10-Q, current reports on Form 8-K and other filings each of which are accessible on the SEC's website at These and other important factors could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management's estimates as of the date of this press release. While the Company may elect to update such forward-looking statements at some point in the future, except as required by law, it disclaims any obligation to do so, even if subsequent events cause our views to change. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of this press release. Contacts Jonae BarnesSVP, Investor Relations and Corporate Joyce AllaireLifeSci AdvisorsJallaire@